Synexus Germany has eight Dedicated Research Centres with access to more than 12 million patients.
These centres were part of the 2009 acquisition of Clinpharm. Working to a nearly identical recruitment model the centres have easily been integrated into the Synexus global network of Dedicated Research Centres. Germany, with its large population and significant pharmaceutical identity, is a key market for Synexus and its clients in pharma, biotech and CROs.
(T) +44 (0)1257 230 723